Kala Bio, Inc. (KALA)
2.23
-0.06
(-2.62%)
USD |
NASDAQ |
May 29, 16:00
2.23
0.00 (0.00%)
Pre-Market: 20:00
Kala Bio EPS Diluted (Quarterly) : -0.1365 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -0.6184 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.621M |
| Total Expenses (Quarterly) | 1.621M |
| Enterprise Value | 32.69M |
| Earnings Yield | -6.20K% |
| Normalized Earnings Yield | -7251.47 |